Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $963.9M | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B |
| Gross profit | $401.2M | $485.3M | $519.1M | $583.9M | $643.3M | $738.3M |
| Operating income | -$1.6M | $60.9M | $87.6M | $123.9M | $155.7M | $184.7M |
| Net income | -$9.8M | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M |
| Diluted EPS | -$0.18 | $0.84 | $1.29 | $1.62 | $2.03 | $2.13 |
| Operating cash flow | $165.3M | $147.2M | $114.3M | $145.2M | $220.8M | $297.4M |
| Free cash flow | $119.3M | $119.3M | $69.3M | $110.9M | $185.7M | $215.7M |
| Gross margin | 41.6% | 45.2% | 45.1% | 46.4% | 47.4% | 48.7% |
| Operating margin | -0.2% | 5.7% | 7.6% | 9.9% | 11.5% | 12.2% |
| Net margin | -1.0% | 4.5% | 6.5% | 7.5% | 8.9% | 8.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $338.0M | $339.8M | $355.2M | $355.4M | $382.5M | $384.2M | $393.9M | $381.9M |
| Gross profit | $161.1M | $157.5M | $173.0M | $172.0M | $184.5M | $186.4M | $195.4M | $184.8M |
| Operating income | $45.9M | $37.3M | $36.6M | $41.0M | $46.9M | $42.6M | $54.2M | $44.2M |
| Net income | $35.7M | $28.4M | $27.9M | $30.1M | $32.6M | $27.8M | $38.0M | $41.0M |
| Diluted EPS | $0.61 | $0.48 | $0.46 | $0.49 | $0.54 | $0.46 | $0.64 | $0.68 |
| Operating cash flow | $68.5M | $47.3M | $68.7M | $40.6M | $83.3M | $75.0M | $98.5M | $40.7M |
| Free cash flow | $57.9M | $38.0M | $65.3M | $19.5M | $69.6M | $52.5M | $74.0M | $24.7M |
| Gross margin | 47.7% | 46.4% | 48.7% | 48.4% | 48.2% | 48.5% | 49.6% | 48.4% |
| Operating margin | 13.6% | 11.0% | 10.3% | 11.5% | 12.3% | 11.1% | 13.8% | 11.6% |
| Net margin | 10.6% | 8.4% | 7.9% | 8.5% | 8.5% | 7.2% | 9.6% | 10.7% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | Voigt Michel James· CHIEF HUMAN RESOURCES OFFICER | Gift | 65 | $0.00 | $0.00 | filing |
| 2026-06-05 | Lloyd Brian G.· CHIEF LEGAL OFFICER, SECRETARY | Gift | 2,000 | $0.00 | $0.00 | filing |
| 2026-05-20 | Gunderson Thomas James | Option exercise | 13,750 | $52.17 | $717,337.50 | filing |
| 2026-05-20 | Gunderson Thomas James | Option exercise | 7,500 | $52.17 | $391,275.00 | filing |
| 2026-05-18 | Ward Lynne | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Ward Scott R. | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Gunderson Thomas James | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Evans Stephen C. | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Kaiser Laura S. | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Perez Silvia | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Carpenter Lonny J | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | MCDONNELL MICHAEL R | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-18 | Millner F. Ann | Award | 3,457 | $0.00 | $0.00 | filing |
| 2026-05-11 | Smith Christian Adam· Chief Commercial Officer | Buy | 1,626 | $61.00 | $99,186.00 | filing |
| 2026-05-07 | Ward Lynne | Sale | 5,000 | $62.61 | $313,035.00 | filing |
| 2026-05-07 | Lloyd Brian G.· CHIEF LEGAL OFFICER, SECRETARY | Buy | 2,000 | $62.63 | $125,250.00 | filing |
| 2026-05-06 | Aronson Martha Goldberg· President and CEO | Buy | 2,000 | $60.44 | $120,880.00 | filing |
| 2026-05-06 | Parra Raul Jr.· CFO AND TREASURER | Buy | 1,500 | $61.01 | $91,515.00 | filing |
| 2026-05-05 | Voigt Michel James· CHIEF HUMAN RESOURCES OFFICER | Buy | 2,250 | $60.65 | $136,462.50 | filing |
| 2026-02-26 | Voigt Michel James· CHIEF HUMAN RESOURCES OFFICER | Tax withholding | 6,698 | $78.02 | $522,577.96 | filing |
| 2026-02-26 | Peterson Neil· CHIEF OPERATING OFFICER | Tax withholding | 6,061 | $78.02 | $472,879.22 | filing |
| 2026-02-26 | Parra Raul Jr.· CFO AND TREASURER | Tax withholding | 5,778 | $78.02 | $450,799.56 | filing |
| 2026-02-26 | Lloyd Brian G.· CHIEF LEGAL OFFICER, SECRETARY | Tax withholding | 5,778 | $78.02 | $450,799.56 | filing |
| 2026-02-26 | Smith Christian Adam· Chief Commercial Officer | Tax withholding | 2,018 | $78.02 | $157,444.36 | filing |
| 2026-02-26 | Peterson Neil· CHIEF OPERATING OFFICER | Award | 17,002 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.